M Schaapveld

Summary

Affiliation: Comprehensive Cancer Center North-Netherlands
Country: The Netherlands

Publications

  1. ncbi request reprint Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy
    Wouter K de Jong
    Department of Pulmonology, University Medical Center Groningen, University of Groningen, NL 9700 RB, Groningen, The Netherlands
    Eur J Cancer 44:123-30. 2008
  2. pmc The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands
    Michael Schaapveld
    Comprehensive Cancer Center North Netherlands, PO Box 330, Groningen 9700 AH, The Netherlands
    Breast Cancer Res Treat 110:189-97. 2008
  3. ncbi request reprint The prognostic effect of the number of histologically examined axillary lymph nodes in breast cancer: stage migration or age association?
    Michael Schaapveld
    Comprehensive Cancer Center North Netherlands, P O Box 330, Groningen, 9700 AH, The Netherlands
    Ann Surg Oncol 13:465-74. 2006
  4. ncbi request reprint Variability in axillary lymph node dissection for breast cancer
    Michael Schaapveld
    Comprehensive Cancer Center North Netherlands CCCN, Groningen, The Netherlands
    J Surg Oncol 87:4-12. 2004
  5. ncbi request reprint Quality of adjuvant CMF chemotherapy for node-positive primary breast cancer: a population-based study
    Michael Schaapveld
    Comprehensive Cancer Center North Netherlands, P O Box 330, 9700 AH Groningen, The Netherlands
    J Cancer Res Clin Oncol 130:581-90. 2004
  6. doi request reprint Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study
    Michael Schaapveld
    Comprehensive Cancer Center North Netherlands CCCN, P O Box 330, 9700 AH Groningen, The Netherlands
    J Clin Oncol 26:1239-46. 2008
  7. pmc Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy
    M Schaapveld
    Comprehensive Cancer Center North Netherlands, PO Box 330, 9700 AH Groningen, The Netherlands
    Br J Cancer 93:520-8. 2005
  8. ncbi request reprint Soft tissue sarcoma--compliance with guidelines
    P H Nijhuis
    Department of Surgical Oncology, Groningen University Hospital, Groningen, The Netherlands
    Cancer 91:2186-95. 2001
  9. ncbi request reprint Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase protein expression on survival in adjuvantly treated stage III colon cancer patients
    J L Westra
    Department of Medical Genetics, University Medical Center Groningen, Groningen, The Netherlands
    Ann Oncol 16:1646-53. 2005
  10. doi request reprint A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the Do
    A K L Reyners
    Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
    Ann Oncol 23:2896-902. 2012

Collaborators

Detail Information

Publications30

  1. ncbi request reprint Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy
    Wouter K de Jong
    Department of Pulmonology, University Medical Center Groningen, University of Groningen, NL 9700 RB, Groningen, The Netherlands
    Eur J Cancer 44:123-30. 2008
    ..53). Thymic epithelial tumours are rare. Excess mortality was observed in the majority of tumours. Surgery offers the best perspectives, even if the resection is incomplete...
  2. pmc The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands
    Michael Schaapveld
    Comprehensive Cancer Center North Netherlands, PO Box 330, Groningen 9700 AH, The Netherlands
    Breast Cancer Res Treat 110:189-97. 2008
    ..The impact of age and adjuvant therapy on contralateral breast cancer (CBC) risk and prognostic significance of CBC were evaluated...
  3. ncbi request reprint The prognostic effect of the number of histologically examined axillary lymph nodes in breast cancer: stage migration or age association?
    Michael Schaapveld
    Comprehensive Cancer Center North Netherlands, P O Box 330, Groningen, 9700 AH, The Netherlands
    Ann Surg Oncol 13:465-74. 2006
    ..The considerable variation observed in axillary staging prompted this population-based study, which evaluated the prognostic effect of a variable number of pathologically examined nodes...
  4. ncbi request reprint Variability in axillary lymph node dissection for breast cancer
    Michael Schaapveld
    Comprehensive Cancer Center North Netherlands CCCN, Groningen, The Netherlands
    J Surg Oncol 87:4-12. 2004
    ..The variation in number of reported axillary lymph nodes and its effect on the axillary nodal stage were studied and the implications are discussed...
  5. ncbi request reprint Quality of adjuvant CMF chemotherapy for node-positive primary breast cancer: a population-based study
    Michael Schaapveld
    Comprehensive Cancer Center North Netherlands, P O Box 330, 9700 AH Groningen, The Netherlands
    J Cancer Res Clin Oncol 130:581-90. 2004
    ..The Comprehensive Cancer Center North Netherlands (CCCN) breast cancer working group performed a retrospective audit of treatment guideline adherence and quality of CMF in hospitals in the CCCN area...
  6. doi request reprint Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study
    Michael Schaapveld
    Comprehensive Cancer Center North Netherlands CCCN, P O Box 330, 9700 AH Groningen, The Netherlands
    J Clin Oncol 26:1239-46. 2008
    ..To assess the risk of secondary nonbreast cancers (SNBCs) in a recently treated population-based cohort of breast cancer patients focused on the association with treatment and prognostic implications...
  7. pmc Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy
    M Schaapveld
    Comprehensive Cancer Center North Netherlands, PO Box 330, 9700 AH Groningen, The Netherlands
    Br J Cancer 93:520-8. 2005
    ..The considerable variation in BCS-rates is more consistent with variations in surgeon preferences than patient's choice...
  8. ncbi request reprint Soft tissue sarcoma--compliance with guidelines
    P H Nijhuis
    Department of Surgical Oncology, Groningen University Hospital, Groningen, The Netherlands
    Cancer 91:2186-95. 2001
    ..Special attention should be paid to older patients, who significantly more often were not referred to a specialized center...
  9. ncbi request reprint Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase protein expression on survival in adjuvantly treated stage III colon cancer patients
    J L Westra
    Department of Medical Genetics, University Medical Center Groningen, Groningen, The Netherlands
    Ann Oncol 16:1646-53. 2005
    ..The effect of TP 53 mutation status, which is thought to be functionally linked to TS inhibition, was also examined...
  10. doi request reprint A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the Do
    A K L Reyners
    Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
    Ann Oncol 23:2896-902. 2012
    ..We investigated the efficacy of celecoxib (C), a selective COX-2 inhibitor, added to docetaxel (Taxotere)/carboplatin (DC) in advanced ovarian cancer...
  11. doi request reprint Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands
    L De Munck
    Department of Research, Comprehensive Cancer Centre North East, Groningen, The Netherlands
    Breast Cancer Res Treat 129:229-33. 2011
    ..Of all HER2-positive patients who received adjuvant chemotherapy, 94% received trastuzumab. The implementation of trastuzumab in clinical practice was realized within 8 months after introduction of the new guideline...
  12. ncbi request reprint Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma
    A Diepstra
    Department of Pathology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
    Lancet 365:2216-24. 2005
    ..Because presentation of EBV antigenic peptides can elicit vigorous immune responses, we investigated associations of the HLA region with EBV-positive and EBV-negative Hodgkin's lymphoma...
  13. doi request reprint Effect of hospital characteristics on outcome of patients with gastric cancer: a population based study in North-East Netherlands
    E J M Siemerink
    Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, P O Box 30 001, 9700 RB, Groningen, The Netherlands
    Eur J Surg Oncol 36:449-55. 2010
    ..This study aims to assess the influence of hospital type, referral pattern and proximal or distal location of the tumour on the ultimate survival...
  14. ncbi request reprint Soft tissue sarcoma: why not treated?
    F Farshadpour
    Department of Surgical Oncology, Groningen University Hospital, Groningen, The Netherlands
    Crit Rev Oncol Hematol 54:77-83. 2005
    ..The present study was performed to investigate whether withholding treatment was based on disease specific aspects, patients' general health condition, comorbidity or a combination of these...
  15. ncbi request reprint Oesophageal cancer in The Netherlands: increasing incidence and mortality but improving survival
    Lucia M A Crane
    Department of Surgery, Division of Surgical Oncology, University Medical Center Groningen, University of Groningen, P O Box 30 001, 9700 RB, Groningen, The Netherlands
    Eur J Cancer 43:1445-51. 2007
    ..An increasing incidence has been reported for several parts of the Western world. We studied time trends in incidence, mortality and survival for oesophageal cancer in the Netherlands during 1989-2003...
  16. pmc Breslow thickness in the Netherlands: a population-based study of 40 880 patients comparing young and elderly patients
    S Kruijff
    Department of Surgical Oncology, University Medical Center Groningen, Groningen, The Netherlands
    Br J Cancer 107:570-4. 2012
    ..The aim of this study was to assess trends in melanoma incidence, Breslow thickness (BT), and melanoma survival among young and elderly patients in the Netherlands...
  17. doi request reprint Safety and cost-effectiveness of shortening hospital follow-up after breast cancer treatment
    W Lu
    Department of Epidemiology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands
    Br J Surg 99:1227-33. 2012
    ..The aim of this study was to evaluate the clinical effects and costs of four different strategies for follow-up after breast cancer treatment...
  18. pmc Risk and prognostic significance of metachronous contralateral testicular germ cell tumours
    M Schaapveld
    Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Br J Cancer 107:1637-43. 2012
    ..Testicular germ cell tumour (TGCT) patients are at increased risk of developing a contralateral testicular germ cell tumour (CTGCT). It is unclear whether TGCT treatment affects CTGCT risk...
  19. ncbi request reprint Randomised Phase III study of biweekly 24-h infusion of high-dose 5FU with folinic acid and oxaliplatin versus monthly plus 5-FU/folinic acid in first-line treatment of advanced colorectal cancer
    G A P Hospers
    Department of Medical Oncology, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands
    Ann Oncol 17:443-9. 2006
    ..A phase III study was started to compare oxaliplatin/5FU/LV in the first-line with bolus FU/LV in metastatic colorectal cancer...
  20. ncbi request reprint Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma
    Mirjam J A Engelen
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University Medical Center Groningen, Groningen, The Netherlands
    Cancer 106:589-98. 2006
    ..For this report, the authors evaluated the effects of primary surgery by a gynecologic oncologist on treatment outcome...
  21. doi request reprint Impact of the number of histologically examined lymph nodes on prognosis in colon cancer: a population-based study in the Netherlands
    Wendy Kelder
    Department of Surgery, University Medical Centre Groningen, Groningen, The Netherlands
    Dis Colon Rectum 52:260-7. 2009
    ..The impact of the reported number of lymph nodes at pathologic examination of colon specimens on survival was studied...
  22. pmc Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility
    M M de Jong
    Department of Medical Oncology, University Hospital, Groningen, The Netherlands
    J Med Genet 39:225-42. 2002
    ..This will facilitate determination of population attributable risks, understanding of gene-gene interactions, and improving estimates of genetic cancer risks...
  23. pmc Better survival in patients with esophageal cancer after surgical treatment in university hospitals: a plea for performance by surgical oncologists
    Christian Verhoef
    Department of Surgical Oncology, Groningen University Medical Center, University of Groningen, P O Box 30 001, 9700, RB, Groningen, The Netherlands
    Ann Surg Oncol 14:1678-87. 2007
    ..This study aims to assess the influence of surgeon-related expertise and hospital volume on the relative survival of operated esophageal cancer patients...
  24. doi request reprint Treatment and outcome in muscle invasive bladder cancer: a population-based survey
    Anna M Leliveld
    Department of Urology, University Medical Center Groningen, Hanzeplein 1, P O Box 30 001, 9700 RB, Groningen, The Netherlands
    World J Urol 28:439-44. 2010
    ..To assess treatments and survival of patients with muscle invasive bladder cancer (MIBC) in the Comprehensive Cancer Center Northern Netherlands (CCCN) region...
  25. ncbi request reprint Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients
    Jantine L Westra
    Department of Medical Genetics, University of Groningen, Netherlands
    J Clin Oncol 23:5635-43. 2005
    ....
  26. doi request reprint Implementation of sentinel node biopsy in breast cancer patients in the Netherlands
    Vincent K Y Ho
    Comprehensive Cancer Centre Middle Netherlands, Utrecht, The Netherlands
    Eur J Cancer 44:683-91. 2008
    ..We examined the extent of use over time of SNB in women who were considered eligible for SNB on the basis of their clinical status...
  27. ncbi request reprint HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma
    Arjan Diepstra
    Department of Pathology and Laboratory Medicine, University Medical Center Groningen, University of Groningen, The Netherlands
    J Clin Oncol 25:3101-8. 2007
    ..The neoplastic Hodgkin Reed-Sternberg (HRS) cells in classical Hodgkin's lymphoma (cHL) are derived from B cells. The frequency of HLA class II downregulation and its effect on prognosis are unknown...
  28. ncbi request reprint No increased susceptibility to breast cancer from combined CHEK2 1100delC genotype and the HLA class III region risk factors
    Mirjam M de Jong
    Department of Medical Oncology, University Medical Centre Groningen, P O Box 30 001, 9700 RB Groningen, The Netherlands
    Eur J Cancer 41:1819-23. 2005
    ..In contrast, the effect of 1100delC mutation on breast cancer risk was limited to individuals without HLA risk haplotype, suggesting a mutual excluding effect between these risk factors...
  29. ncbi request reprint The human leukocyte antigen region and colorectal cancer risk
    Mirjam M de Jong
    Department of Gastroenterology, University Hospital Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands
    Dis Colon Rectum 48:303-6. 2005
    ....
  30. ncbi request reprint The HLA class III subregion is responsible for an increased breast cancer risk
    Mirjam M de Jong
    Department of Medical Oncology, University Medical Center Groningen, Hanzeplein 1, PO Box 30 001, 9700 RB Groningen, The Netherlands
    Hum Mol Genet 12:2311-9. 2003
    ..The results reveal a potential role of the HLA class III subregion in susceptibility to breast cancer in patients at moderate familial risk...